Search Clinical Trials
Our researchers are currently in need of adult and pediatric study participants to help us pursue better treatments and cures. Participants may receive medical evaluations and procedures, study medication, disease-related education and possible financial compensation for time, travel and participation.
Select a Condition or Specialty
- Allergy
- Alpha-1 Antitrypsin Deficiency
- Asthma
- Cardiology
- Chronic Obstructive Pulmonary Disease (COPD)
- COVID-19 (Coronavirus)
- Cystic Fibrosis
- Eczema (Atopic Dermatitis)
- Environmental & Occupational Health
- Eosinophilic Granulomatosis with Polyangiitis (EGPA)
- Food Allergy
- Gastroenterology
- Idiopathic Pulmonary Fibrosis (IPF)
- Interstitial Lung Disease (Pulmonary Fibrosis)
- Lung Cancer
- Nontuberculous Mycobacteria (NTM)
- Oncology
- Pulmonary Hypertension (PH)
- Respiratory (Pulmonary)
- Rheumatology
- Sarcoidosis
All Clinical Trials
Treating Deployment-Related Asthma with Supplements
Many people returning from military deployment have developed asthma as a result of inhaling hazardous materials. Exposures to diesel, burn pits, biomass smoke and sandstorms during deployment likely play a role. Some people with deployment-related asthma do not respond well to standard asthma medications.
- Gender
- Any
- Ages
- 18-70
- Compensation
- Provided
- Time Required
- 5-6 clinic visits over 18-22 weeks
SUNRISE Trial for Oral Steroid Dependent Asthma
People with severe asthma are often dependent on oral corticosteroids, such as prednisone, to treat their condition. Researchers are currently investigating whether a new biologic treatment called tezepelumab may help to reduce or remove the need for these steroid medications.
- Gender
- Any
- Ages
- 18-80
- Compensation
- Provided
- Time Required
- 14 visits over approximately 12 months. Most visits will last about 2 hours, but a few could take up to 4 hours.
OCEAN Study for EGPA
People with eosinophilic granulomatosis with polyangiitis (EGPA) are needed for the OCEAN clinical trial. The study compares two medications: mepolizumab (NUCALA), which is administered by an injection once a month, and depemokimab, an investigational medication that is injected twice a year.
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- Once a month visits for approximately 15 months
Skin, Airway & Esophageal Epithelial Barriers in Youth
Researchers want to better understand if the causes of asthma, eczema, food allergies, eosinophilic esophagitis and GERD can be determined at a cellular level.
- Gender
- Any
- Ages
- 2-21
- Compensation
- Provided
- Time Required
- Not Specified
CHARM Study for Asthma
Researchers want to improve medical care for asthmatics with new mobile health technologies. Study participants will use at-home technologies to track and record health data and participate in surveys and questionnaires about their health.
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- Participants will have a 2-3 in-person clinic visits of 45-90 minutes over 6-12 months.
Identifying Characteristics and Patterns of Asthma
Our researchers are working to identify the clinical, physiologic, genetic and molecular characteristics of asthmatics.
- Gender
- Any
- Ages
- 5+
- Compensation
- Provided
- Time Required
- 2-4 office visits and up to 3 follow up phone calls
Adult Trials
SUNRISE Trial for Oral Steroid Dependent Asthma
People with severe asthma are often dependent on oral corticosteroids, such as prednisone, to treat their condition. Researchers are currently investigating whether a new biologic treatment called tezepelumab may help to reduce or remove the need for these steroid medications.
- Gender
- Any
- Ages
- 18-80
- Compensation
- Provided
- Time Required
- 14 visits over approximately 12 months. Most visits will last about 2 hours, but a few could take up to 4 hours.
OCEAN Study for EGPA
People with eosinophilic granulomatosis with polyangiitis (EGPA) are needed for the OCEAN clinical trial. The study compares two medications: mepolizumab (NUCALA), which is administered by an injection once a month, and depemokimab, an investigational medication that is injected twice a year.
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- Once a month visits for approximately 15 months
Skin, Airway & Esophageal Epithelial Barriers in Youth
Researchers want to better understand if the causes of asthma, eczema, food allergies, eosinophilic esophagitis and GERD can be determined at a cellular level.
- Gender
- Any
- Ages
- 2-21
- Compensation
- Provided
- Time Required
- Not Specified
CHARM Study for Asthma
Researchers want to improve medical care for asthmatics with new mobile health technologies. Study participants will use at-home technologies to track and record health data and participate in surveys and questionnaires about their health.
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- Participants will have a 2-3 in-person clinic visits of 45-90 minutes over 6-12 months.
Identifying Characteristics and Patterns of Asthma
Our researchers are working to identify the clinical, physiologic, genetic and molecular characteristics of asthmatics.
- Gender
- Any
- Ages
- 5+
- Compensation
- Provided
- Time Required
- 2-4 office visits and up to 3 follow up phone calls
Pediatric Trials
Skin, Airway & Esophageal Epithelial Barriers in Youth
Researchers want to better understand if the causes of asthma, eczema, food allergies, eosinophilic esophagitis and GERD can be determined at a cellular level.
- Gender
- Any
- Ages
- 2-21
- Compensation
- Provided
- Time Required
- Not Specified
Identifying Characteristics and Patterns of Asthma
Our researchers are working to identify the clinical, physiologic, genetic and molecular characteristics of asthmatics.
- Gender
- Any
- Ages
- 5+
- Compensation
- Provided
- Time Required
- 2-4 office visits and up to 3 follow up phone calls